Genesys Industries – GEIN OTC
This precision metals fabricating and manufacturer is in the right place at the right time . These are the people who industry calls when a part breaks on an assembly line shutting down the complete line . They can turn most orders around and delivered within 24 hours or less. From drawing board to fully machined part in just a few hours to get any line machinery operating again is their specialty .
This Covid 19 designated stock is gaining support by the investment community .Presently thinly traded and with a yearly high of $1.01 we expect these shares to move significantly higher in the coming months.
Management has expressed a desire to grow by acquisition as it moves forward with its strategic business model. We urge all serious investors to place these shares immediately on their BUY LIST
We ask all buyers to be patient when purchasing
WEBSITE – FINANCIALS – SEC FILINGS – Latest 10Q
DEEMED CRUCIAL SUPPLIER TO COVID 19 SUPPLIER
NEW YORK, NY – TheNewswire – April 7, 2020 – Genesys Industries, Inc (OTC:GEIN) (OTCMKTS:GEIN) $GEIN – today announced that the company has purchased a new CNC Machine tool to support its customer orders at its Florida factory. Delivery and onboarding of the machinery will be completed this month.
Company Spokesperson, commented: “This is an additional purchase of advanced manufacturing equipment at our Florida facility which will allow the company to support its ever growing customer list. We are quietly executing our strategy in building out the necessary infrastructure to support our new and existing customers.”
The financing of this purchase will be provided in part by TCP term loan and partially by a new commercial bank loan. TCP, is an entity controlled by the Company’s sole officer and largest stockholder. TCP continues to assist the company with its short term capital needs at very favorable terms. Genesys Industries is grateful to TCP and its management for supporting the company since inception.
About Genesys Industries
Genesys Industries is a diversified multi-industry advanced manufacturer of complex components and products. The company is a vertically integrated precision products manufacturer with core emphasis on product design, engineering and precision manufacturing of complex components and products. Some of the industries served include Automation, Aviation, Automotive, Building Materials, Food Processing, Industrial, Maritime, Medical, Railroad, Oil and Gas, Packaging, Telecom, Textiles, Pulp Paper, Transportation and many more. Follow us on twitter @genesysind or $GEIN
For more information on Genesys Industries, please visit www.genesysindustries.com
NEW YORK, NY – TheNewswire – March 24, 2020 – Genesys Industries, Inc (OTC:GEIN) (OTCMKTS:GEIN) $GEIN – a diversified precision products manufacturer announced today that in the event a Stay-at-Home Mandate is issued due to the COVID-19 virus, Genesys Industries has been issued a stay-at-home exemption as a supplier of critical components for the medical industry. Such exemptions issued are for companies deemed to be Life Sustaining Businesses, which includes Medical Equipment and Supplies Manufacturing. Stay-At-Home Exemptions are issued to businesses and their employees if they are necessary for the production of essential supplies needed during the outbreak.
Coronavirus Disease 2019 (COVID-19, SARS-CoV-2) is a respiratory disease caused by the SARSCoV-2 virus. Depending on the severity of COVID-19’s international impacts, outbreak conditions can affect all aspects of daily life, including travel, trade, tourism, food supplies, financial markets with all of these aspects heavily impacting global supply chains.
Genesys Industries is a U.S. manufacturer with administrative and production facilities located in Florida and Missouri.
The Company expects that in the coming hours, the State of Florida and Missouri will possibly issue a shelter-in-place order. The Shelter-in-Place order will require citizens to shelter in place at home, and either work at home or not work, unless they are involved in what will be identified as essential businesses or essential infrastructure operations.
A company spokesperson said “We are pleased to be able to continue production of critical medical supplies amidst this global pandemic. Our team is tirelessly working to ensure these components continue to be supplied to the medical professionals and patients who rely on them. Our production facilities will continue to remain open to meet the needs of the medical community during this pressing time.”
About Genesys Industries
Genesys Industries is a diversified multi-industry advanced manufacturer of complex components and products. The company is a vertically integrated precision products manufacturer with core emphasis on product design, engineering and precision manufacturing of complex components and products. Some of the industries served include Aviation, Automotive, Building Materials, Food Processing, Industrial, Maritime, Medical, Railroad, Oil and Gas, Packaging, Telecom, Textiles, Pulp Paper, Transportation and many more. Follow us on twitter @genesysind or $GEIN
Safe Harbor Statement
This press release contains forward-looking statements. Actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. Statements contained in this press release regarding the company intentions, hopes, beliefs, expectations, or predictions of the future are “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based upon the Company’s current expectations, forecasts, and assumptions that are subject to risks, uncertainties, and other factors that could cause actual outcomes and results to differ materially from those indicated by these forward-looking statements. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading “Risk Factors” in the Company’s Financial Reports. This press release does not form any part of a prospectus or offering. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.
Neither PSN nor its owners, members, officers, directors, partners, consultants, nor anyone involved in the publication of this website, is a registered investment adviser or broker-dealer or associated person with a registered investment adviser or broker-dealer and none of the foregoing make any recommendation that the purchase or sale of securities of any company profiled in the PSN website is suitable or advisable for any person or that an investment or transaction in such securities will be profitable. The information contained in the PSN website is not intended to be, and shall not constitute, an offer to sell nor the solicitation of any offer to buy any security. The information presented in the PSN website is provided for informational purposes only and is not to be treated as advice or a recommendation to make any specific investment. Please consult with an independent investment adviser and qualified investment professional before making an investment decision.